APA

Canton V. M., Quiroz-Mercado H., Velez-Montoya R., Lopez-Miranda M. J., Moshfeghi A. A., Shusterman E. M., Kaiser P. K., Sanislo S. R., Gertner M. & Moshfeghi D. M. (20120327). 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. : Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

Chicago

Canton Virgilio Morales, Quiroz-Mercado Hugo, Velez-Montoya Raul, Lopez-Miranda Miriam J, Moshfeghi Andrew A, Shusterman Eugene M, Kaiser Peter K, Sanislo Steven R, Gertner Michael and Moshfeghi Darius M. 20120327. 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. : Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

Harvard

Canton V. M., Quiroz-Mercado H., Velez-Montoya R., Lopez-Miranda M. J., Moshfeghi A. A., Shusterman E. M., Kaiser P. K., Sanislo S. R., Gertner M. and Moshfeghi D. M. (20120327). 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. : Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

MLA

Canton Virgilio Morales, Quiroz-Mercado Hugo, Velez-Montoya Raul, Lopez-Miranda Miriam J, Moshfeghi Andrew A, Shusterman Eugene M, Kaiser Peter K, Sanislo Steven R, Gertner Michael and Moshfeghi Darius M. 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. : Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye. 20120327.